Institutional investors purchased a net $2.2 million shares of GHDX during the quarter ended June 2014 and now own 91.59% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 1.0 Million shares of Genomic Health Inc
CAMBER CAPITAL MANAGEMENT LLC Bought 975.0 Thousand shares of Genomic Health Inc
BLACKROCK ADVISORS LLC Bought 216.0 Thousand shares of Genomic Health Inc